Area of research
Oncology · Genetics
Research interest
Research interests include BRCA gene mutations in cancer, Cancer Cells and Metastasis, Advanced Breast Cancer Therapies, and Cancer Treatment and Pharmacology.
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
Parity and lactation induce T-cell-mediated breast cancer protection
Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial
Cancer Risks Associated With <i>TP53</i> Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
Deciphering breast cancer: from biology to the clinic
Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Rare germline copy number variants (CNVs) and breast cancer risk
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells
Homologous recombination DNA repair defects in PALB2-associated breast cancers
Heritable DNA methylation marks associated with susceptibility to breast cancer
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Patient-derived xenograft models of breast cancer and their predictive power
Breast-Cancer Risk in Families with Mutations in <i>PALB2</i>
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
Cancer Stem Cells: Current Status and Evolving Complexities